Orphan Diseases — Go Beyond Pharma 101
October 20, 2015
PM360 Online: October 19, 2015 Print: October 2015 By Brenda Snow http://www.pm360online.com/orphan-diseases-go-beyond-pharma-101/ Why orphan diseases are different Orphan diseases hold a special status with pharma companies, because regulations encourage research and development and because each patient on treatment is a high-lifetime value customer. When a few individual customers generate a large proportion of revenue, companies should go […]